Impaired balance - FDA Gives Accelerated Approval for Risky Alzheimer's Pill

The U.S. Food and Drug Administration granted accelerated approval for the Alzheimer's disease drug lecanemab. The drug, a monoclonal antibody, binds to amyloid beta in the...